YSB - Public Comps and Valuation Multiples

YSB Overview

About YSB

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.

Founded

2018

HQ

Employees

6.8K+

Website

ysbang.cn

Sectors

Pharmacies
Vertical E-commerce
Consumer E-commerce
HealthTech

Financials

Last FY Revenue $2.3B

Last FY EBITDA $19.8M

EV

$305M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

YSB Financials

In the same period, YSB achieved $28.5M in LTM net income.

See YSB valuation multiples based on analyst estimates

YSB P&L

In the most recent fiscal year, YSB reported revenue of $2.3B and EBITDA of $19.8M.

YSB expects next 12-month revenue of XXX and NTM EBITDA of XXX

See YSB valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	n/a	XXX	$2.3B	XXX	XXX	XXX
Gross Profit	n/a	XXX	$233M	XXX	XXX	XXX
Gross Margin	n/a	XXX	10%	XXX	XXX	XXX
EBITDA	n/a	XXX	$19.8M	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	1%	XXX	XXX	XXX
EBIT	n/a	XXX	-$10.7M	XXX	XXX	XXX
EBIT Margin	n/a	XXX	0%	XXX	XXX	XXX
Net Profit	$28.5M	XXX	$1.9M	XXX	XXX	XXX
Net Margin	n/a	XXX	0%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for YSB including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, YSB achieved $2.3B in revenue and $19.8M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	n/a	Analyst estimates available to subscribers	$2.3B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$233M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	10.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	n/a	Analyst estimates available to subscribers	$19.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	n/a	Analyst estimates available to subscribers	0.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	n/a	Analyst estimates available to subscribers	-$10.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	n/a	Analyst estimates available to subscribers	-0.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$28.5M	Analyst estimates available to subscribers	$1.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	n/a	Analyst estimates available to subscribers	0.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for YSB

This financial data table provides comprehensive performance metrics for YSB, a company based in Hong Kong. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, YSB reported $2.3B in total revenue.
Fiscal year EBITDA was $19.8M.
The company maintained a gross profit margin of 10.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 0.9%.
Net profit margin reached 0.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for YSB. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

YSB Stock Performance

YSB has current market cap of HKD 4.2B (or $545M), and EV of HKD 2.4B (or $305M).

Market Cap Evolution

YSB Stock Data

As of January 16, 2026, YSB's stock price is HKD 6 (or $1).

See YSB trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$305M	$545M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

YSB Valuation Multiples

YSB's trades at 0.1x EV/Revenue multiple, and 15.4x EV/EBITDA.

See valuation multiples for YSB and 15K+ public comps

YSB Financial Valuation Multiples

As of January 16, 2026, YSB has market cap of $545M and EV of $305M.

Equity research analysts estimate YSB's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

YSB has a P/E ratio of 21.3x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$545M	XXX	$545M	XXX	XXX	XXX
EV (current)	$305M	XXX	$305M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	0.1x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	15.4x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-28.5x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	21.3x	XXX	21.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	3.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get YSB Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

YSB Margins & Growth Rates

YSB's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $36K for the same period.

YSB's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

YSB's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for YSB and other 15K+ public comps

YSB Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$36K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	11%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial

YSB Public Comps

See public comps and valuation multiples for Pharmacies and Vertical E-commerce comps

	EV/Revenue			EV/EBITDA
	2025E	2026E	2027E	2025E	2026E	2027E
Sigma Healthcare	XXX	XXX	XXX	XXX	XXX	XXX
MedPlus India	XXX	XXX	XXX	XXX	XXX	XXX
SC Ropharma	XXX	XXX	XXX	XXX	XXX	XXX
D1000 Varejo Farma	XXX	XXX	XXX	XXX	XXX	XXX
Profarma Distribuidora	XXX	XXX	XXX	XXX	XXX	XXX
XXXXXXXX	XXX	XXX	XXX	XXX	XXX	XXX
XXXXXXXX	XXX	XXX	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc.

YSB M&A and Investment Activity

YSB acquired XXX companies to date.

Last acquisition by YSB was XXXXXXXX, XXXXX XXXXX XXXXXX . YSB acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).

See M&A valuation multiples

Latest Acquisitions by YSB

Acquired Company	EV	EV/Revenue	EV/EBITDA
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX
XXXXXXXXX	XXX	XXX	XXX

Get Verified M&A Valuation Multiples

Start Free Trial

About YSB

When was YSB founded?	YSB was founded in 2018.
Where is YSB headquartered?	YSB is headquartered in Hong Kong.
How many employees does YSB have?	As of today, YSB has 6.8K+ employees.
Who is the CEO of YSB?	YSB's CEO is Mr. Buzhen Zhang.
Is YSB publicy listed?	Yes, YSB is a public company listed on HKG.
What is the stock symbol of YSB?	YSB trades under 09885 ticker.
When did YSB go public?	YSB went public in 2023.
Who are competitors of YSB?	Similar companies to YSB include e.g. Sigma Healthcare, MedPlus India, SC Ropharma, D1000 Varejo Farma.
What is the current market cap of YSB?	YSB's current market cap is $545M
Is YSB profitable?	Yes, YSB is EBITDA-positive (as of the last 12 months).

YSB Valuation Multiples

Discover revenue and EBITDA valuation multiples for YSB and similar public comparables like SC Ropharma, D1000 Varejo Farma, and Profarma Distribuidora.

YSB Overview

About YSB

Founded

HQ

Employees

Website

Sectors

Financials

EV

Valuation Multiples

Valuation Multiples for 15K+ Public Comps

YSB Financials

YSB P&L

Financial Performance Summary for YSB

Fiscal Year Performance

YSB Stock Performance

Market Cap Evolution

YSB Stock Data

Benchmark Trading Valuation Multiples by Industry

YSB Valuation Multiples

EV/Revenue (LTM) Evolution

YSB Financial Valuation Multiples

Get YSB Valuation Multiples

YSB Margins & Growth Rates

YSB Operational Valuation Multiples

Valuation Multiples Across 220+ Verticals

YSB Public Comps

YSB M&A and Investment Activity

Latest Acquisitions by YSB

Get Verified M&A Valuation Multiples

About YSB

Join Now Or Talk To Us

Join Our Newsletter